Related Experiment Video

Updated: Aug 14, 2026

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction
04:43

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction

Published on: October 11, 2024

Adenoviral strategies for the gene therapy of cancer

Kate Louise Relph1, Kevin J Harrington, Hardev Pandha

  • 1Department of Oncology, St George's, University of London, London UK.

Seminars in Oncology
|December 13, 2005
PubMed

Insights

Adenoviral vectors show promise for cancer gene therapy, enabling targeted delivery to tumors for enhanced treatment. Ongoing research aims to improve potency and selectivity over traditional methods.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Cancer gene therapy research is advancing, with a focus on developing specific, non-toxic treatments.
  • Adenoviral vectors are widely utilized for gene transfer in cancer clinical trials.
  • Understanding the adenoviral life cycle and tumor antigens facilitates targeted vector delivery.

Purpose of the Study:

  • To review the fundamental principles of using adenoviral vectors for cancer gene therapy.
  • To discuss the clinical potential and applications of adenoviral vectors in oncology.
  • To summarize current, completed, and ongoing clinical trials involving adenoviral vectors for cancer treatment.

Main Methods:

  • Review of existing literature on adenoviral vectors in cancer gene therapy.
  • Analysis of strategies for targeting adenoviral vectors to specific tumors.
  • Discussion of novel tumor-killing approaches utilizing adenoviral vectors.

Main Results:

  • Adenoviral vectors are a leading platform for gene transfer in cancer therapy.
  • Targeting strategies enhance the safety and efficacy of adenoviral vectors for systemic administration.
  • Novel therapeutic approaches offer greater potency and selectivity compared to chemotherapy and radiation.

Conclusions:

  • Adenoviral vectors hold significant potential for clinical application in cancer gene therapy.
  • Targeted delivery is critical for the successful systemic use of adenoviral vectors.
  • Continued research and clinical trials are essential to realize the full potential of adenoviral vector-based cancer therapies.

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...